ATP binding cassette transporters and drug resistance in breast cancer.
about
An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cellsThe fate of chemoresistance in triple negative breast cancer (TNBC)Micelle-like nanoparticles as carriers for DNA and siRNATowards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancerA mutation in intracellular loop 4 affects the drug-efflux activity of the yeast multidrug resistance ABC transporter Pdr5pNeoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancerDNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response.Interaction of oxazaphosphorines with multidrug resistance-associated protein 4 (MRP4).The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cellsDeregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepiloneConsequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model.CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases.ABC transporters: unvalidated therapeutic targets in cancer and the CNSA serum protein profile predictive of the resistance to neoadjuvant chemotherapy in advanced breast cancers.Two SNPs of ATP-binding cassette B1 gene on the risk and prognosis of colorectal cancerA review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence.Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters.The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance.Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs.Regulation of drug resistance by human pregnane X receptor in breast cancer.P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cellsMolecular markers of multiple drug resistance in breast cancer.DualChip microarray as a new tool in cancer research.Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.Metabolism of ATP-binding cassette drug transporter inhibitors: complicating factor for multidrug resistance.High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survivalPrognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patientsEmodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.Association of MDR1 gene polymorphisms with the risk of hepatocellular carcinoma in the Chinese Han populationManagement of advanced breast cancer with the epothilone B analog, ixabepiloneOverexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells.Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances.Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy.Importance of ABCC1 for cancer therapy and prognosis.Effect of pregnane X receptor expression on drug resistance in breast cancer.Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.The α7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to taxanes.Quercetin inhibits proliferation and drug resistance in KB/VCR oral cancer cells and enhances its sensitivity to vincristine.
P2860
Q21245772-ECA15B45-0F1A-4514-9B17-9A2A64D9B721Q26775232-06A6F820-D18F-46AF-B529-E816D5EF46AFQ27001558-3C6BA463-8C55-4A73-873E-B904181FD371Q28291499-649ECC84-8EEB-4543-A4BD-84A3907AC23CQ28478735-5333D826-74C0-49CD-84FE-A19A9CF0C4ABQ28706276-7A6943B2-5569-4928-905D-2C75A08F90F0Q33816178-57F1FF28-57B6-4AC1-8B65-488401CCBB3BQ33954656-AE379DB1-1691-4CD9-A6CF-F6442AAB0ECFQ34048154-1D4DAC97-12E5-486A-82E9-6ED6F8A0D853Q34103963-AF68841E-58D8-4066-8178-1D17EC9E2E58Q34274930-DAE603A2-8E0A-4E3C-8A71-9B7530FE94C0Q34574059-37A8CADB-FB71-4433-8CDD-5FC4E2D98B60Q34983912-88C54550-A2A8-4AD8-B539-C95B800C02A6Q35056738-8A4316E2-36DC-482F-8133-95BEC7AA51D5Q35497722-1D1798B3-99B4-44B8-9961-7DB28F597178Q35632295-E04966CB-33CA-41FC-BD9C-09F34A618CCDQ35868560-4DCC1420-23F5-4B1D-8DA2-B1729A41F783Q35919726-BFFBBF2D-7E17-4B8D-87BF-959D6CAF0EDAQ35956193-27913CAB-88C3-427C-8363-77C2A85B1FE4Q36027132-D088E4F6-C8D6-4C5A-8354-D1822F3B7710Q36083299-184339DC-C290-4847-9237-4D9100B92BC1Q36174338-A8C4D6F0-5307-45FC-88AF-A94D9D19E788Q36447943-24089E42-6142-443C-8DCA-6C578B0C0957Q36481097-B6D35287-8241-4943-BD04-0783748038B0Q36525551-FC0B5D18-0BAD-44AA-9B98-6F536EADE638Q36572571-C39A3F1E-A861-473E-BBC5-9D827FF2DDBFQ36576187-F8EE0B97-BB91-4F49-8E4A-F70EE66A1C09Q36613823-FF03439D-25F6-4066-8778-138C33FAB067Q36645798-79D79FF0-9380-49C6-863D-EF5A27CF58D5Q37008882-C8F1BDE2-1BE7-4894-BF59-70E92FF78C34Q37371415-CA9AF1E8-8459-4565-BA56-98B54B4C3734Q37403186-08BF619E-100F-4D30-9D7F-C0E60E99A134Q37563940-EFD7742B-3DF2-44C2-AF64-D7564144C477Q37805491-1895A836-D3B1-41A5-BDCD-C69454AC594BQ38071981-6911B4B9-5A41-40B9-B67E-F4721E865EB1Q38199535-2D4B797C-056E-4D95-BA47-804C86AB24D1Q38376011-3A95C8E1-52EE-4604-B6C7-CE527D9B07F2Q38813380-0B98DBFC-091D-47B0-B05E-9361AF1D7461Q38825012-29691208-F362-4D23-A05F-552CF61AAC18Q38928050-4C321227-532F-4554-8F3B-200C085782F5
P2860
ATP binding cassette transporters and drug resistance in breast cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
ATP binding cassette transporters and drug resistance in breast cancer.
@ast
ATP binding cassette transporters and drug resistance in breast cancer.
@en
type
label
ATP binding cassette transporters and drug resistance in breast cancer.
@ast
ATP binding cassette transporters and drug resistance in breast cancer.
@en
prefLabel
ATP binding cassette transporters and drug resistance in breast cancer.
@ast
ATP binding cassette transporters and drug resistance in breast cancer.
@en
P356
P1476
ATP binding cassette transporters and drug resistance in breast cancer.
@en
P2093
P356
10.1677/ERC.0.0100043
P577
2003-03-01T00:00:00Z